Evidence map›Paper›PMID 40748057›Full record

ReviewClinical microbiology reviews2025

Determinants of respiratory syncytial virus and human metapneumovirus transmission.

David A Foley, David W Smith, Ian Barr, Hannah C Moore, Mark Nicol, Christopher C Blyth

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Molecular Evolution of theMicroorganisms · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David A FoleyDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Western Australia, Australia.ORCID 0000-0002-8622-7809
David W SmithDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Western Australia, Australia.
Ian BarrWHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Hannah C MooreWesfarmers Centre of Vaccines and Infectious Diseases, Kid's Research Institute Australia, University of Western Australia, Perth, Western Australia, Australia.
Mark NicolWesfarmers Centre of Vaccines and Infectious Diseases, Kid's Research Institute Australia, University of Western Australia, Perth, Western Australia, Australia.
Christopher C BlythDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Western Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMMARYRespiratory syncytial virus and human metapneumovirus are major causes of respiratory illness globally, particularly affecting children and older adults. Despite their clinical significance, substantial gaps persist in understanding the determinants of their transmission. This review examines the multifaceted factors shaping RSV and hMPV transmission, including viral structure and evolution, host behaviors and viral shedding dynamics, the influence of environmental conditions on viral survival, the roles of population- and community-level transmission networks, and the impact of SARS-CoV-2. Additionally, we explore prevention strategies, including immunizations and non-pharmaceutical interventions, to reduce transmission in high-risk settings.

Indexed as

MetapneumovirusParamyxoviridae InfectionsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsCOVID-19HumansSARS-CoV-2Virus Sheddingenvironmenthuman metapneumovirusprimary preventionrespiratory syncytial virusrespiratory virustranmission networktransmissionviral shedding

Identifiers

PMID40748057
PMCPMC12424386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.